PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Drug regulations tied to fewer prescriptions of effective gout drug

Study finds that fewer patients with gout received useful colchicine drug after FDA actions led to 50x increase in price

2015-04-09
(Press-News.org) Well intentioned, but costly and potentially problematic. That's how researchers describe the end result of a decision by the Food and Drug Administration (FDA) to regulate colchicine, a drug used to treat gout, among other ailments. Fewer patients are actually now taking it, and it has come at a cost to their wallets, says study leader Aaron Kesselheim of Brigham and Women's Hospital and the Harvard Medical School in the US. The findings¹ appear in the Journal of General Internal Medicine,² published by Springer.

Colchicine had been sold at low cost for many years in the US. It is widely used to treat gout, and is the primary treatment for a rare inflammatory disease called familial Mediterranean fever. Its availability on the US market predated the FDA's regulatory authority to ensure the safety and effective use of prescription drugs, and numerous manufacturers made the drug, selling it for about $0.09 per pill.

In 2007, with the FDA's encouragement, one of these manufacturers conducted a small clinical trial demonstrating the safety and efficacy of a short course of the drug in managing acute flares of gout. The FDA approved this manufacturer's version, granting sole market rights and ordering all unapproved versions off the market by January 2011. Exclusive rights for at least seven years were also granted for its use to treat familial Mediterranean fever, although no new studies were done on its effectiveness to treat this disease. The manufacturer of the new version, called Colcrys, sold the drug for about $5.00 per pill.

To gauge the impact of these market changes, Kesselheim and his colleagues conducted a retrospective cohort study of close to 217,000 commercially insured patients. Between 2009 and 2012, these patients were all newly diagnosed with either gout or familial Mediterranean fever.

They found that the odds of a familial Mediterranean fever patient being prescribed colchicine within 30 days of receiving such a diagnosis dropped by 7.6 percent per month after the regulations were put in place, while the odds for gout sufferers dropped by 0.5 percent per month. They also found that average patients' monthly total prescription bills rose from $418 to $651.

One of the FDA's justifications for Colcrys' approval was new warnings in Colcrys' label about the potentially lethal risks of co-prescribing colchicine with the antibiotic clarithromycin. But Kesselheim and his colleagues found no change in the rates of co-prescriptions of these two drugs, or co-prescription of colchicine with the transplant rejection medication cyclosporine, another potentially deadly combination.

Kesselheim and his team say that although the FDA's attempts to strengthen its regulatory oversight related to unapproved drugs are laudable, it has come at a price to those who need colchicine. "The way this case was handled has led to a potentially useful drug, colchicine, being prescribed to fewer patients, while there have also been substantial cost increases for those who do use it and no evidence of reductions in unsafe co-prescriptions," says Kesselheim, in summarizing the findings.

INFORMATION:

References: 1. Kesselheim, A.S. et al (2015). Reductions in Use of Colchicine after FDA Enforcement of Market Exclusivity in a Commercially Insured Population, Journal of General Internal Medicine. DOI 10.1007/s11606-015-3285-7 2. The Journal of General Internal Medicine is the official journal of the Society for General Internal Medicine.



ELSE PRESS RELEASES FROM THIS DATE:

Shakespeare's plays reveal his psychological signature

2015-04-09
Shakespeare is such a towering literary figure that any new insight into the man, or his work, tends to generate a jolt of excitement in academic and non-academic communities of Shakespeare aficionados. Applying psychological theory and text-analyzing software, researchers at the University of Texas at Austin have discovered a unique psychological profile that characterizes Shakespeare's established works, and this profile strongly identifies Shakespeare as an author of the long-contested play Double Falsehood. The findings are published in Psychological Science, a journal ...

Dispersant used to clean Deepwater Horizon spill more toxic to corals than the oil

Dispersant used to clean Deepwater Horizon spill more toxic to corals than the oil
2015-04-09
The dispersant used to remediate the 2010 Deepwater Horizon oil spill in the Gulf of Mexico is more toxic to cold-water corals than the spilled oil, according to a study conducted at Temple University. The study comes on the eve of the spill's fifth anniversary, April 20th. In this collaborative study between researchers from Temple and the Pennsylvania State University, the researchers exposed three cold-water coral species from the Gulf to various concentrations of the dispersant and oil from the Deepwater Horizon well. They found that the dispersant is toxic to the ...

The benefits of storytelling in video games

2015-04-09
April 9, 2015 - A wealth of studies have shown that violent video games contribute to antisocial and aggressive behavior. But what makes those games appealing in the first place? One possibility is that storytelling plays a role, particularly if it lets players engage in meaningful choices. A new study suggests that non-violent video games that capitalize on such storytelling have prosocial benefits that could ultimately be helpful to clinical disorders such as autism. "The motivation to engage in and enjoy video games corresponds with principals that apply to ...

York scientists lead study on new treatment for prostate cancer

2015-04-09
Scientists at the University of York have discovered a potential new treatment for prostate cancer using low temperature plasmas (LTPs). Published in the British Journal of Cancer (BJC), the study is the first time LTPs have been applied on cells grown directly from patient tissue samples. It is the result of a unique collaboration between the York Plasma Institute in the Department of Physics and the Cancer Research Unit (CRU) in York's Department of Biology. Taking both healthy prostate cells and prostate cancer tissue cells from a single patient, the study allowed ...

More food, low pollution effort gains traction

2015-04-09
FROSTBURG, MD (April 9, 2015)--Nitrogen fertilizers make it possible to feed more people in the world than ever before. However, too much of it can also harm the environment. Professor Eric Davidson, director of the University of Maryland Center for Environmental Science's Appalachian Laboratory, has been leading a group of scientists, economists, social scientists, and agriculture experts in figuring out how to produce more food while lowering pollution at the same time. He calls it a "Mo Fo Lo Po": more food, low pollution. "The main objective is to produce abundant, ...

New evidence supports success of fecal transplants in treatment of Clostridium difficile infection

2015-04-09
MINNEAPOLIS/ST.PAUL (4/9/15) - Research published in the open access journal Microbiome offers new evidence for the success of fecal microbial transplantation (FMT) in treating severe Clostridium difficile infection (CDI), a growing problem worldwide that leads to thousands of fatalities every year. Research led by Michael Sadowsky, Alex Khoruts, and colleagues at the University of Minnesota in collaboration with the Rob Knight Lab at the University of Colorado, Boulder, reveals that healthy changes to a patient's microbiome are sustained for up to 21 weeks after transplant, ...

A revealing new look at the secretive black tinamou

A revealing new look at the secretive black tinamou
2015-04-09
After decades in ornithological obscurity, one of the world's least-known birds is finally coming to light thanks to the persistence of a small group of researchers. Pablo Negret, Oscar Garzón, Pablo Stevenson, and Oscar Laverde-R. of the Universidad de los Andes have just published the results of their year-long study of the Black Tinamou (Tinamus osgoodi hershkovitzi) in The Auk: Ornithological Advances, including new ecological information as well as some of the first video and sound recordings of this elusive species. The Black Tinamou is a chicken-sized bird ...

Recovery potential for the world's coral reef fish

Recovery potential for the worlds coral reef fish
2015-04-09
A simple test of the number of fish living on a coral reef can be used as a roadmap to restore degraded reefs and fishers' livelihoods according to a global study published in the journal Nature. An international team of marine scientists surveyed more than 800 coral reefs worldwide to develop a diagnostic test of reef health. "By studying remote and marine protected areas, we were able to estimate how many fish would be on a coral reef without fishing, and how long it should take newly protected areas to recover," says study lead author, Dr Aaron MacNeil from the ...

A grateful heart is a healthier heart

2015-04-09
WASHINGTON - Recognizing and giving thanks for the positive aspects of life can result in improved mental, and ultimately physical, health in patients with asymptomatic heart failure, according to research published by the American Psychological Association. "We found that more gratitude in these patients was associated with better mood, better sleep, less fatigue and lower levels of inflammatory biomarkers related to cardiac health," said lead author Paul J. Mills, PhD, professor of family medicine and public health at the University of California, San Diego. The study ...

UCLA researchers deliver large particles into cells at high speed

2015-04-09
A new device developed by UCLA engineers and doctors eventually help scientists study the development of disease, enable them to capture improved images of the inside of cells and lead to other improvements in medical and biological research. The researchers created a highly efficient automated tool that delivers nanoparticles, enzymes, antibodies, bacteria and other "large-sized" cargo into mammalian cells at the rate of 100,000 cells per minute -- significantly faster than current technology, which works at about one cell per minute. The research, published online ...

LAST 30 PRESS RELEASES:

UMass Amherst Nursing Professor Emerita honored as ‘Living Legend’

New guidelines aim to improve cystic fibrosis screening

Picky eaters by day, buffet by night: Butterfly, moth diets sync to plant aromas

Pennington Biomedical’s Dr. Leanne Redman honored with the E. V. McCollum Award from the American Society for Nutrition

CCNY physicists uncover electronic interactions mediated via spin waves

Researchers’ 3D-printing formula may transform future of foam

Nurture more important than nature for robotic hand

Drug-delivering aptamers target leukemia stem cells for one-two knockout punch

New study finds that over 95% of sponsored influencer posts on Twitter were not disclosed

New sea grant report helps great lakes fish farmers navigate aquaculture regulations

Strain “trick” improves perovskite solar cells’ efficiency

How GPS helps older drivers stay on the roads

Estrogen and progesterone stimulate the body to make opioids

Dancing with the cells – how acoustically levitating a diamond led to a breakthrough in biotech automation

Machine learning helps construct an evolutionary timeline of bacteria

Cellular regulator of mRNA vaccine revealed... offering new therapeutic options

Animal behavioral diversity at risk in the face of declining biodiversity

Finding their way: GPS ignites independence in older adult drivers

Antibiotic resistance among key bacterial species plateaus over time

‘Some insects are declining but what’s happening to the other 99%?’

Powerful new software platform could reshape biomedical research by making data analysis more accessible

Revealing capillaries and cells in living organs with ultrasound

American College of Physicians awards $260,000 in grants to address equity challenges in obesity care

Researchers from MARE ULisboa discover that the European catfish, an invasive species in Portugal, has a prolonged breeding season, enhancing its invasive potential

Rakesh K. Jain, PhD, FAACR, honored with the 2025 AACR Award for Lifetime Achievement in Cancer Research

Solar cells made of moon dust could power future space exploration

Deporting immigrants may further shrink the health care workforce

Border region emergency medical services in migrant emergency care

Resident physician intentions regarding unionization

Healthy nutrition and physical lifestyle choices lower cancer mortality risk for survivors, new ACS study finds

[Press-News.org] Drug regulations tied to fewer prescriptions of effective gout drug
Study finds that fewer patients with gout received useful colchicine drug after FDA actions led to 50x increase in price